John C. Brady

Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease and Serological Evidence for <i>Chlamydia pneumoniae</i> Infection

Jeffrey L. Anderson, Joseph B. Muhlestein, John F. Carlquist et al. · Circulation · 1999 · 337 citations

Medicine, Cardiology, Pharmacology +13

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Angeles Alvarez Secord, Kirsten B. Burdett, Kouros Owzar et al. · Clinical Cancer Research · 2020 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas

Hope E. Uronis, Johanna C. Bendell, Ivy Altomare et al. · The Oncologist · 2013 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Modulation of circulating protein biomarkers following <scp>TRC</scp>105 (anti‐endoglin antibody) treatment in patients with advanced cancer

Yingmiao Liu, Mark D. Starr, John C. Brady et al. · Cancer Medicine · 2014 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib

Yingmiao Liu, Jing Lyu, Kirsten B. Burdett et al. · Molecular Cancer Therapeutics · 2020 · 30 citations

Medicine, Oncology, Pharmacology +17